Global and United States Trigeminal Neuralgia Therapeutics Market Report & Forecast 2024-2031

Report ID: 1838837 | Published Date: Oct 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Trigeminal Neuralgia Therapeutics Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Trigeminal Neuralgia Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Trigeminal Neuralgia Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Trigeminal Neuralgia Therapeutics Market Size for the Year 2017-2028
    1.3 Trigeminal Neuralgia Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Trigeminal Neuralgia Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Trigeminal Neuralgia Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Trigeminal Neuralgia Therapeutics Market Dynamics
        1.4.1 Trigeminal Neuralgia Therapeutics Industry Trends
        1.4.2 Trigeminal Neuralgia Therapeutics Market Drivers
        1.4.3 Trigeminal Neuralgia Therapeutics Market Challenges
        1.4.4 Trigeminal Neuralgia Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Trigeminal Neuralgia Therapeutics by Type
    2.1 Trigeminal Neuralgia Therapeutics Market Segment by Type
        2.1.1 NeuroRelease TN
        2.1.2 Onabotulinumtoxin A
        2.1.3 Oxytocin
        2.1.4 Raxatrigine Hydrochloride
        2.1.5 U-2902
        2.1.6 Others
    2.2 Global Trigeminal Neuralgia Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Trigeminal Neuralgia Therapeutics Market Size by Type (2017-2028)
    2.4 United States Trigeminal Neuralgia Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Trigeminal Neuralgia Therapeutics Market Size by Type (2017-2028)
3 Trigeminal Neuralgia Therapeutics by Application
    3.1 Trigeminal Neuralgia Therapeutics Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Trigeminal Neuralgia Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Trigeminal Neuralgia Therapeutics Market Size by Application (2017-2028)
    3.4 United States Trigeminal Neuralgia Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Trigeminal Neuralgia Therapeutics Market Size by Application (2017-2028)
4 Global Trigeminal Neuralgia Therapeutics Competitor Landscape by Company
    4.1 Global Trigeminal Neuralgia Therapeutics Market Size by Company
        4.1.1 Top Global Trigeminal Neuralgia Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Trigeminal Neuralgia Therapeutics Revenue by Player (2017-2022)
    4.2 Global Trigeminal Neuralgia Therapeutics Concentration Ratio (CR)
        4.2.1 Trigeminal Neuralgia Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Trigeminal Neuralgia Therapeutics in 2021
        4.2.3 Global Trigeminal Neuralgia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Trigeminal Neuralgia Therapeutics Headquarters, Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Trigeminal Neuralgia Therapeutics Headquarters and Area Served
        4.3.2 Global Trigeminal Neuralgia Therapeutics Companies Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Trigeminal Neuralgia Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Trigeminal Neuralgia Therapeutics Market Size by Company
        4.5.1 Top Trigeminal Neuralgia Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Trigeminal Neuralgia Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Trigeminal Neuralgia Therapeutics Market Size by Region
    5.1 Global Trigeminal Neuralgia Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Trigeminal Neuralgia Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Trigeminal Neuralgia Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Trigeminal Neuralgia Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Trigeminal Neuralgia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Trigeminal Neuralgia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Trigeminal Neuralgia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Trigeminal Neuralgia Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Trigeminal Neuralgia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Allergan, Inc.
        7.1.1 Allergan, Inc. Company Details
        7.1.2 Allergan, Inc. Business Overview
        7.1.3 Allergan, Inc. Trigeminal Neuralgia Therapeutics Introduction
        7.1.4 Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022)
        7.1.5 Allergan, Inc. Recent Development
    7.2 Biogen, Inc.
        7.2.1 Biogen, Inc. Company Details
        7.2.2 Biogen, Inc. Business Overview
        7.2.3 Biogen, Inc. Trigeminal Neuralgia Therapeutics Introduction
        7.2.4 Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022)
        7.2.5 Biogen, Inc. Recent Development
    7.3 Kineta, Inc.
        7.3.1 Kineta, Inc. Company Details
        7.3.2 Kineta, Inc. Business Overview
        7.3.3 Kineta, Inc. Trigeminal Neuralgia Therapeutics Introduction
        7.3.4 Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022)
        7.3.5 Kineta, Inc. Recent Development
    7.4 Merz Pharma GmbH & Co. KgaA
        7.4.1 Merz Pharma GmbH & Co. KgaA Company Details
        7.4.2 Merz Pharma GmbH & Co. KgaA Business Overview
        7.4.3 Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Introduction
        7.4.4 Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022)
        7.4.5 Merz Pharma GmbH & Co. KgaA Recent Development
    7.5 Trigemina, Inc.
        7.5.1 Trigemina, Inc. Company Details
        7.5.2 Trigemina, Inc. Business Overview
        7.5.3 Trigemina, Inc. Trigeminal Neuralgia Therapeutics Introduction
        7.5.4 Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022)
        7.5.5 Trigemina, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Trigeminal Neuralgia Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Trigeminal Neuralgia Therapeutics Market Trends
    Table 3. Trigeminal Neuralgia Therapeutics Market Drivers
    Table 4. Trigeminal Neuralgia Therapeutics Market Challenges
    Table 5. Trigeminal Neuralgia Therapeutics Market Restraints
    Table 6. Global Trigeminal Neuralgia Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Trigeminal Neuralgia Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Trigeminal Neuralgia Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Trigeminal Neuralgia Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Trigeminal Neuralgia Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Trigeminal Neuralgia Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Trigeminal Neuralgia Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Trigeminal Neuralgia Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Trigeminal Neuralgia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trigeminal Neuralgia Therapeutics as of 2021)
    Table 15. Top Players of Trigeminal Neuralgia Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Trigeminal Neuralgia Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Trigeminal Neuralgia Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Trigeminal Neuralgia Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Trigeminal Neuralgia Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Trigeminal Neuralgia Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Trigeminal Neuralgia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Trigeminal Neuralgia Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Trigeminal Neuralgia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Trigeminal Neuralgia Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Trigeminal Neuralgia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Trigeminal Neuralgia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Trigeminal Neuralgia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Allergan, Inc. Company Details
    Table 31. Allergan, Inc. Business Overview
    Table 32. Allergan, Inc. Trigeminal Neuralgia Therapeutics Product
    Table 33. Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Allergan, Inc. Recent Development
    Table 35. Biogen, Inc. Company Details
    Table 36. Biogen, Inc. Business Overview
    Table 37. Biogen, Inc. Trigeminal Neuralgia Therapeutics Product
    Table 38. Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Biogen, Inc. Recent Development
    Table 40. Kineta, Inc. Company Details
    Table 41. Kineta, Inc. Business Overview
    Table 42. Kineta, Inc. Trigeminal Neuralgia Therapeutics Product
    Table 43. Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Kineta, Inc. Recent Development
    Table 45. Merz Pharma GmbH & Co. KgaA Company Details
    Table 46. Merz Pharma GmbH & Co. KgaA Business Overview
    Table 47. Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Product
    Table 48. Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Merz Pharma GmbH & Co. KgaA Recent Development
    Table 50. Trigemina, Inc. Company Details
    Table 51. Trigemina, Inc. Business Overview
    Table 52. Trigemina, Inc. Trigeminal Neuralgia Therapeutics Product
    Table 53. Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Trigemina, Inc. Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Trigeminal Neuralgia Therapeutics Product Picture
    Figure 2. Global Trigeminal Neuralgia Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Trigeminal Neuralgia Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Trigeminal Neuralgia Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Trigeminal Neuralgia Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Trigeminal Neuralgia Therapeutics Market Share in Global 2017-2028
    Figure 7. Trigeminal Neuralgia Therapeutics Report Years Considered
    Figure 8. Product Picture of NeuroRelease TN
    Figure 9. Product Picture of Onabotulinumtoxin A
    Figure 10. Product Picture of Oxytocin
    Figure 11. Product Picture of Raxatrigine Hydrochloride
    Figure 12. Product Picture of U-2902
    Figure 13. Product Picture of Others
    Figure 14. Global Trigeminal Neuralgia Therapeutics Market Share by Type in 2022 & 2028
    Figure 15. Global Trigeminal Neuralgia Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Trigeminal Neuralgia Therapeutics Market Share by Type (2017-2028)
    Figure 17. United States Trigeminal Neuralgia Therapeutics Market Share by Type in 2022 & 2028
    Figure 18. United States Trigeminal Neuralgia Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Trigeminal Neuralgia Therapeutics Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Others
    Figure 23. Global Trigeminal Neuralgia Therapeutics Market Share by Application in 2022 & 2028
    Figure 24. Global Trigeminal Neuralgia Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Trigeminal Neuralgia Therapeutics Market Share by Application (2017-2028)
    Figure 26. United States Trigeminal Neuralgia Therapeutics Market Share by Application in 2022 & 2028
    Figure 27. United States Trigeminal Neuralgia Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Trigeminal Neuralgia Therapeutics Market Share by Application (2017-2028)
    Figure 29. North America Trigeminal Neuralgia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Trigeminal Neuralgia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Trigeminal Neuralgia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Trigeminal Neuralgia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Allergan, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2017-2022)
    Figure 58. Biogen, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2017-2022)
    Figure 59. Kineta, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2017-2022)
    Figure 60. Merz Pharma GmbH & Co. KgaA Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2017-2022)
    Figure 61. Trigemina, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan, Inc.
Biogen, Inc.
Kineta, Inc.
Merz Pharma GmbH & Co. KgaA
Trigemina, Inc.
Frequently Asked Questions
Trigeminal Neuralgia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Trigeminal Neuralgia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Trigeminal Neuralgia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Burns Treatment

Burns Treatment market is segmented by region (country), players, by Type and by Application. Pla ... Read More